Paroxetine vs pregabalin for the management of neuropathic pain in multiple sclerosis

doi:10.5313/wja.v3.i2.181

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11741)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

428

WORD

374

HTML

7701

Figures (1-3)

299

Tables (1-5)

253

Sum=9055

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1338

Download

1348

Sum=2686

Jul 27, 2014 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Anesthesiology

ISSN

2218-6182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Anesthesiol. Jul 27, 2014; 3(2): 181-188
Published online Jul 27, 2014. doi: 10.5313/wja.v3.i2.181

Table 2 Paroxetine/pregabalin flexible-dose titration schedule

Schedule	Dosage
Schedule	Paroxetine	Pregabalin
Day 1	20 mg once daily	75 mg twice daily
Day 8	40 mg once daily	150 mg twice daily
Day 15	50 mg once daily	300 mg twice daily

Flexible-dose titration schedule for each group is presented. Assuming therapy was well-tolerated patients were instructed to increase dosages as indicated above. If, however, at any point patients experienced intolerable side effects they were instructed to contact study investigators for tailored dosing instructions.

Citation: Turcotte DA, Doupe M, Torabi M, Gomori AJ, Ethans K, Esfahani F, Galloway K, Namaka MP. Paroxetine vs pregabalin for the management of neuropathic pain in multiple sclerosis. World J Anesthesiol 2014; 3(2): 181-188
URL: https://www.wjgnet.com/2218-6182/full/v3/i2/181.htm
DOI: https://dx.doi.org/10.5313/wja.v3.i2.181